Page last updated: 2024-10-17

3-hydroxybutyric acid and Depressive Disorder, Major

3-hydroxybutyric acid has been researched along with Depressive Disorder, Major in 1 studies

3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jia, Y1
Hui, L1
Sun, L1
Guo, D1
Shi, M1
Zhang, K1
Yang, P1
Wang, Y1
Liu, F1
Shen, O1
Zhu, Z1

Other Studies

1 other study available for 3-hydroxybutyric acid and Depressive Disorder, Major

ArticleYear
Association Between Human Blood Metabolome and the Risk of Psychiatric Disorders.
    Schizophrenia bulletin, 2023, 03-15, Volume: 49, Issue:2

    Topics: 3-Hydroxybutyric Acid; Attention Deficit Disorder with Hyperactivity; Depressive Disorder, Major; Ge

2023